Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?June 30, 2023GoutRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Methotrexate does not impair sperm quality, small study findsJune 21, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricingJune 16, 2023Business of MedicineAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatrics
High-intensity interval training has sustainable effects in patients with inflammatory arthritisJune 13, 2023Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Why not both? Dual biologics for treatment-resistant RA and PsAJune 12, 2023Rheumatoid ArthritisPsoriatic Arthritis
Is ChatGPT a friend or foe of medical publishing?June 9, 2023Business of MedicineRheumatoid Arthritis
ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDsJune 1, 2023Psoriatic ArthritisRheumatoid Arthritis
FDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
FDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPediatricsPsoriatic Arthritis
